国药控股(01099)：建议委任杨秉华为执行董事

Core Viewpoint - China National Pharmaceutical Group (国药控股) announced the resignation of Mr. Sun Jinglin as an executive director and member of the board's strategy and investment committee, effective immediately, and proposed the appointment of Mr. Yang Binghua as the new executive director [1] Group 1 - Mr. Sun Jinglin submitted his resignation on November 6, 2025, due to work arrangement reasons [1] - The board has resolved to recommend the appointment of Mr. Yang Binghua as the executive director [1]